Depo-Provera Settlement Amounts 2026: MDL 3140 Compensation Guide
Depo-Provera settlement amounts in 2026 range from $100,000 to $1.5 million or more, depending on meningioma diagnosis severity, duration of use, and documented economic losses. The Depo-Provera MDL 3140 consolidates thousands of meningioma brain tumor claims against Pfizer and Pharmacia. If you were diagnosed with an intracranial meningioma after using Depo-Provera, you may qualify for significant Depo-Provera settlement compensation. See all settlement amounts by case type →
⚖️ 3,769+ Cases Filed
💰 $100K–$1.5M+ Range
🏥 Meningioma Claims
🆓 Free Case Review
No Win, No Fee
Depo-Provera Settlement Amounts 2026: What to Expect
Depo-Provera settlement amounts have not yet been officially set because MDL 3140 has not reached global resolution. However, based on analogous pharmaceutical mass torts, plaintiff attorneys project Depo-Provera settlement compensation tiers ranging from $100,000 for less severe cases to more than $1.5 million for those with aggressive meningioma requiring surgery, radiation, or causing permanent neurological disability. The individual Depo-Provera settlement value depends on your specific medical record, documented usage history, and injury severity.
A 2023 study published in the British Medical Journal demonstrated a 5.6-fold increased risk of intracranial meningioma in women who used high-dose progestin medications including Depo-Provera for more than one year — foundational science that strengthens every plaintiff’s causation argument in the MDL. A 2022 epidemiological review in JAMA Oncology corroborated these findings with dose-response relationships consistent with legal causation standards.
Latest Depo-Provera MDL 3140 Updates — May 2026
May 2026: 3,769 Cases — Daubert Hearings Imminent
As of May 2026, MDL 3140 in the Northern District of Illinois holds 3,769 active Depo-Provera settlement claims. Judge Matthew Kennelly has ordered Daubert hearings on causation and general liability experts. Plaintiff attorneys anticipate these rulings will clear the path for bellwether trial scheduling, driving global Depo-Provera settlement negotiations.
March 2026: Pfizer Daubert Challenge Denied on Key Experts
In a significant win for plaintiffs seeking Depo-Provera settlement compensation, Judge Kennelly denied Pfizer’s motion to exclude two of the plaintiff’s primary causation experts. The ruling allowed testimony regarding the biological mechanism linking synthetic progestins to meningioma cell proliferation.
January 2026: New Meningioma Studies Strengthen Causation
Additional peer-reviewed studies published in early 2026 reinforced the causal link between prolonged Depo-Provera use and intracranial meningioma, adding scientific credibility supporting elevated Depo-Provera settlement amounts.
October 2025: FDA Updates Depo-Provera Warning Label
The FDA formally required updated labeling for medroxyprogesterone acetate products, explicitly warning of meningioma risk. This regulatory action significantly strengthens failure-to-warn arguments and could push Depo-Provera settlement amounts above initial projections.
Depo-Provera Settlement Amounts: Tier Breakdown
- Aggressive or recurrent meningioma
- Surgery + radiation required
- Permanent neurological deficit
- Cognitive impairment or disability
- 10+ years Depo-Provera use
- Single surgery, tumor controlled
- Partial neurological deficit
- Extended recovery period
- Significant documented wage loss
- 5–10 years use
- Watch-and-wait diagnosis
- Smaller, non-symptomatic tumor
- Minimal treatment
- Limited economic impact
- 1–5 years use
Who Qualifies for Depo-Provera Settlement Amounts?
To qualify for Depo-Provera settlement compensation in MDL 3140, you generally must meet the following criteria:
- You received Depo-Provera (medroxyprogesterone acetate) injections for at least 12 months
- You were diagnosed with an intracranial meningioma brain tumor
- Your diagnosis occurred after or during your period of Depo-Provera use
- You have medical records documenting both the injection history and tumor diagnosis
- Your claim falls within the applicable statute of limitations for your state
⚡ Find Out If You Qualify for Depo-Provera Settlement Compensation
Free, confidential case review — no obligation, no upfront fees. Our mass tort attorneys respond within 24 hours.
By submitting, you consent to being contacted about your Depo-Provera meningioma claim. No attorney-client relationship is formed until a signed fee agreement is executed. No Win, No Fee.
⚖️ How to File a Depo-Provera Claim: Step-by-Step
Gather Medical RecordsCollect all Depo-Provera injection records from your OB/GYN, clinic, or pharmacy, plus your meningioma diagnosis, imaging (MRI/CT), and all treatment records.
Request a Free Case ReviewContact a mass tort attorney specializing in Depo-Provera settlement claims. Consultations are free and attorneys work on contingency.
File in MDL 3140Your attorney will file a Short Form Complaint in the Northern District of Illinois MDL and place your Depo-Provera claim in the discovery pool.
Complete Plaintiff Fact SheetDocument your complete usage history, tumor diagnosis, treatment timeline, and economic losses to maximize your Depo-Provera settlement amount.
Await Bellwether OutcomesBellwether trial verdicts establish the Depo-Provera settlement damages benchmark, triggering global settlement negotiations with Pfizer.
Key Factors That Affect Depo-Provera Settlement Amounts
Duration of Use
Longer Depo-Provera use (5+ years) correlates with higher tumor risk and stronger causation evidence, increasing your Depo-Provera settlement value.
Tumor Size & Grade
WHO Grade II or III meningiomas command the highest Depo-Provera settlement amounts in the tier system due to greater injury severity.
Treatment Intensity
Craniotomy surgery, stereotactic radiosurgery, or combined treatment protocols significantly increase documented damages and Depo-Provera settlement compensation.
Neurological Impact
Vision loss, hearing loss, cognitive impairment, or motor deficits constitute severe injury categories that support Tier 1 Depo-Provera settlement amounts.
Economic Loss
Lost wages, reduced earning capacity, and future medical care costs add quantifiable damages to your Depo-Provera settlement claim.
Documentation Quality
Complete injection records paired with continuous imaging significantly strengthen your Depo-Provera settlement position in MDL 3140.
💬 Find Out What Your Depo-Provera Settlement May Be Worth
Our network of mass tort attorneys has evaluated thousands of Depo-Provera settlement claims. Get a free, no-obligation case review in minutes.
📞 Call (855) 664-8713 — Free Consultation
No Win, No Fee. Confidential. Available 7 days a week.
Depo-Provera Settlement Amounts vs. Comparable Mass Tort Verdicts
The Depo-Provera MDL follows patterns seen in comparable pharmaceutical mass torts. Roundup (glyphosate) litigation yielded settlements averaging $160,000 per claim in Monsanto’s $10.9 billion global resolution. Talcum powder ovarian cancer verdicts reached $4 billion before J&J’s settlement. While Depo-Provera settlement amounts are still emerging, a well-documented case with serious neurological injury could command substantial individual compensation. Compare all mass tort settlement amounts →
State-by-State Considerations for Depo-Provera Settlement Amounts
Your state’s statute of limitations affects your Depo-Provera claim filing deadline. Most states allow 2–3 years from the date of meningioma diagnosis to file a Depo-Provera claim. States including California, New York, and Illinois extend your filing window using the discovery rule. Contact an attorney immediately to determine your specific statute of limitations for Depo-Provera settlement eligibility.
📚 Related Depo-Provera Resources
Frequently Asked Questions: Depo-Provera Settlement Amounts 2026
How much are Depo-Provera settlement amounts in 2026?
Depo-Provera settlement amounts in 2026 are projected between $100,000 and $1.5 million or more per qualifying plaintiff. No official Depo-Provera settlement amount has been set because MDL 3140 has not reached global resolution. Bellwether trial verdicts expected within 12–18 months will anchor the final global Depo-Provera settlement range.
Who qualifies for a Depo-Provera settlement?
Qualifying plaintiffs generally must have used Depo-Provera for at least 12 months and received a subsequent diagnosis of intracranial meningioma. Medical records documenting both the injection history and tumor diagnosis are essential to establish your Depo-Provera settlement claim.
How long will Depo-Provera settlement amounts take to be paid?
Based on comparable pharmaceutical MDLs, individual claimants typically begin receiving Depo-Provera settlement payments within 2–3 years of filing, though this varies based on MDL pace and bellwether trial outcomes.
Is there a free Depo-Provera settlement amount calculator?
Yes. TortAdvisor provides a free Depo-Provera settlement calculator that estimates your claim’s value based on injury tier, treatment history, and duration of use — using the same methodology plaintiff attorneys use for MDL case evaluation.
What does a Depo-Provera attorney cost?
Mass tort attorneys handling Depo-Provera settlement claims work on contingency — you pay zero attorney fees unless you receive a settlement or verdict. The standard contingency fee in MDL pharmaceutical cases is typically 33–40% of the gross recovery.
Is Pfizer settling Depo-Provera lawsuits?
As of May 2026, Pfizer has not announced a global Depo-Provera settlement. However, plaintiff attorneys expect Depo-Provera settlement negotiations to accelerate significantly following the first bellwether trial results in MDL 3140.
